123 related articles for article (PubMed ID: 14698150)
1. Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinones.
Coelho A; Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E
Bioorg Med Chem Lett; 2004 Jan; 14(2):321-4. PubMed ID: 14698150
[TBL] [Abstract][Full Text] [Related]
2. Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones.
Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E
Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1574-7. PubMed ID: 12499593
[TBL] [Abstract][Full Text] [Related]
3. Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors.
Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Brea J; Raviña E
Bioorg Med Chem Lett; 2002 Jun; 12(12):1575-7. PubMed ID: 12039565
[TBL] [Abstract][Full Text] [Related]
4. Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
Crespo A; Meyers C; Coelho A; Yáñez M; Fraiz N; Sotelo E; Maes BU; Laguna R; Cano E; Lemière GL; Raviña E
Bioorg Med Chem Lett; 2006 Feb; 16(4):1080-3. PubMed ID: 16290144
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones].
Jiang Q; Sun CS
Yao Xue Xue Bao; 1990; 25(8):598-603. PubMed ID: 2082682
[TBL] [Abstract][Full Text] [Related]
6. Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions.
Sotelo E; Fraiz N; Yáñez M; Terrades V; Laguna R; Cano E; Raviña E
Bioorg Med Chem; 2002 Sep; 10(9):2873-82. PubMed ID: 12110307
[TBL] [Abstract][Full Text] [Related]
7. Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
Laguna R; Rodriguez-Liñares B; Cano E; Estevez I; Raviña E; Sotelo E
Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1151-5. PubMed ID: 9246748
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-diones.
Dal Piaz V; Ciciani G; Giovannoni MP
Drug Des Discov; 1996 Mar; 14(1):53-75. PubMed ID: 8854045
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
Yao FM; Sun CS
Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
[TBL] [Abstract][Full Text] [Related]
10. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
[TBL] [Abstract][Full Text] [Related]
11. Pyridazines. XVIII. 6-Aryl-3(2H)-pyridazinones inhibit calcium influx in stimulated platelets.
Montero-Lastres A; Fraiz N; Laguna R; Cano E; Estevez I; Raviña E
Biol Pharm Bull; 1999 Dec; 22(12):1376-9. PubMed ID: 10746173
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitors.
Dal Piaz V; Ciciani G; Giovannoni MP
Farmaco; 1997 Mar; 52(3):173-8. PubMed ID: 9212451
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
Coelho A; Raviña E; Fraiz N; Yáñez M; Laguna R; Cano E; Sotelo E
J Med Chem; 2007 Dec; 50(26):6476-84. PubMed ID: 18031002
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
[TBL] [Abstract][Full Text] [Related]
15. Pyridazine derivatives 32: Stille-based approaches in the synthesis of 5-substituted-6-phenyl-3(2H)-pyridazinones.
Sotelo E; Coelho A; Raviña E
Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):427-30. PubMed ID: 12672999
[TBL] [Abstract][Full Text] [Related]
16. [Studies on synthesis, anticonvulsant activity and the structure--activity relationships of 6-(substituted phenyl)-3 (2H) pyridazinones].
Xu P; Wang SY; Chen Y; Liu WQ; Tao C
Yao Xue Xue Bao; 1991; 26(9):656-60. PubMed ID: 1821084
[TBL] [Abstract][Full Text] [Related]
17. 6-Aryl-4,5-dihydro-3(2H)-pyridazinones. A new class of compounds with platelet aggregation inhibiting and hypotensive activities.
Thyes M; Lehmann HD; Gries J; König H; Kretzschmar R; Kunze J; Lebkücher R; Lenke D
J Med Chem; 1983 Jun; 26(6):800-7. PubMed ID: 6854582
[TBL] [Abstract][Full Text] [Related]
18. 5-Acyl-6-aryl-4-nitro-3(2H)pyridazinones and related 4-amino compounds: synthesis and pharmacological evaluation.
Dal Piaz V; Ciciani G; Turco G; Giovannoni MP; Miceli M; Pirisino R; Perretti M
J Pharm Sci; 1991 Apr; 80(4):341-8. PubMed ID: 1865334
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of 6-(7-theophylline)-3(2H)-pyridazinone.
Corsano S; Strappaghetti G; Ferrini R; Giglioli N
Arch Pharm (Weinheim); 1991 Dec; 324(12):999-1001. PubMed ID: 1815486
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 6-[(4-imidazol-1-yl)-phenyl]-4-phenyl 4,5-dihydro-2H-pyridazin-3-one: a potential blood platelet aggregation inhibitor.
Coudert P; Rubat C; Couquelet J; Tronche P
J Pharm Belg; 1990; 45(3):191-5. PubMed ID: 2401951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
